Secondary Logo

Journal Logo

March 15, 2019 - Volume 33 - Issue 4
pp: F1-F12,597-771

Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice

Ling, Lijun; Wu, Tongjin; To, Kelvin Kai Wang; More

AIDS. 33(4):F1-F12, March 15, 2019.

Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women

d’Ettorre, Gabriella; Borrazzo, Cristian; Pinacchio, Claudia; More

AIDS. 33(4):627-636, March 15, 2019.

Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals

Storm-Larsen, Christopher; Stiksrud, Birgitte; Eriksen, Carsten; More

AIDS. 33(4):645-653, March 15, 2019.

Associations between baseline biomarkers and lung function in HIV-positive individuals

MacDonald, David M.; Zanotto, Alexander D.; Collins, Gary; More

AIDS. 33(4):655-664, March 15, 2019.

HIV-1 detection in the olfactory mucosa of HIV-1-infected participants

Bertero, Luca; Joseph, Sarah Beth; Trunfio, Mattia; More

AIDS. 33(4):665-674, March 15, 2019.

Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors

Gelpi, Marco; Afzal, Shoaib; Fuchs, Andreas; More

AIDS. 33(4):675-683, March 15, 2019.


Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals

Berenguer, Juan; Gil-Martin, Ángela; Jarrin, Inmaculada; More

AIDS. 33(4):685-689, March 15, 2019.

Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women

Zhang, William R.; Scherzer, Rebecca; Estrella, Michelle M.; More

AIDS. 33(4):723-733, March 15, 2019.

HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa

Heffron, Renee; Stalter, Randy; Pyra, Maria; More

AIDS. 33(4):735-744, March 15, 2019.

Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1

The Long-Term Virological Suppression Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord

AIDS. 33(4):745-751, March 15, 2019.

Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?

Trunfio, Mattia; Pinnetti, Carmela; Focà, Emanuele; More

AIDS. 33(4):759-762, March 15, 2019.